Patent · US Active

Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure

US9802985B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH · AT

Inventors

Bernhard Fischer · Wien, AT
Rudolf Lucas · Ekeren, BE
Hendrik Fischer · Wien, AT

Key dates

Filing date	Jun 19, 2013
Grant date	Oct 31, 2017
Priority date	—
Expiry date	Jun 19, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

What is described is a peptide which consists of 7-20, especially 7-17, adjacent amino acids and comprises the hexamer TX1EX2X3E where X1, X2 and X3 may be any natural or unnatural amino acid, where the peptide does not have any TNF receptor binding activity and is cyclized, for use for the treatment and avoidance of the pulmonary form of altitude sickness.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.